IRIS Accounts Production v23.2.0.158 12781731 Board of Directors 1.7.22 30.6.23 30.6.23 22/11/2023 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh127817312022-06-30127817312023-06-30127817312022-07-012023-06-30127817312021-06-30127817312021-07-012022-06-30127817312022-06-3012781731ns10:Originalns15:EnglandWales2022-07-012023-06-3012781731ns14:PoundSterlingns10:Original2022-07-012023-06-3012781731ns10:Originalns10:Director12022-07-012023-06-3012781731ns10:Original2022-07-012023-06-3012781731ns10:Original2023-06-3012781731ns10:Originalns10:PrivateLimitedCompanyLtd2022-07-012023-06-3012781731ns10:Originalns10:SmallEntities2022-07-012023-06-3012781731ns10:Originalns10:Audited2022-07-012023-06-3012781731ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3012781731ns10:SmallCompaniesRegimeForAccountsns10:Original2022-07-012023-06-3012781731ns10:Originalns10:FullAccounts2022-07-012023-06-3012781731ns10:Originalns10:Director22022-07-012023-06-3012781731ns10:Originalns10:RegisteredOffice2022-07-012023-06-3012781731ns10:Original2022-06-3012781731ns10:Originalns5:CurrentFinancialInstruments2023-06-3012781731ns10:Originalns5:CurrentFinancialInstruments2022-06-3012781731ns5:ShareCapitalns10:Original2023-06-3012781731ns5:ShareCapitalns10:Original2022-06-3012781731ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-06-3012781731ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-3012781731ns10:Original2021-07-012022-06-3012781731ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3012781731ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-06-30
REGISTERED NUMBER: 12781731 (England and Wales)




















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2023

FOR

FSE HEALTHCARE LIMITED

FSE HEALTHCARE LIMITED (REGISTERED NUMBER: 12781731)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


FSE HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2023







DIRECTORS: H Marquis
R D Tramasure





REGISTERED OFFICE: 50 Seymour Street
London
W1H 7JG





REGISTERED NUMBER: 12781731 (England and Wales)





AUDITORS: Orcom Civvals Audit Limited
Chartered Accountants and
Statutory Auditors
50 Seymour Street
London
W1H 7JG

FSE HEALTHCARE LIMITED (REGISTERED NUMBER: 12781731)

BALANCE SHEET
30 JUNE 2023

2023 2022
Notes £    £   
CURRENT ASSETS
Stocks - 38,870
Debtors 4 281,766 -
Cash at bank 188,635 66,990
470,401 105,860
CREDITORS
Amounts falling due within one year 5 187,737 36,984
NET CURRENT ASSETS 282,664 68,876
TOTAL ASSETS LESS CURRENT
LIABILITIES

282,664

68,876

CAPITAL AND RESERVES
Called up share capital 100,000 100,000
Retained earnings 182,664 (31,124 )
282,664 68,876

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 November 2023 and were signed on its behalf by:





H Marquis - Director


FSE HEALTHCARE LIMITED (REGISTERED NUMBER: 12781731)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023


1. STATUTORY INFORMATION

FSE Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

FSE HEALTHCARE LIMITED (REGISTERED NUMBER: 12781731)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2023


2. ACCOUNTING POLICIES - continued

Foreign currencies
Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 149,009 -
Amounts owed by group undertakings 85,363 -
Other debtors 47,394 -
281,766 -

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors - 19,639
Amounts owed to group undertakings - 1
Taxation and social security 46,998 -
Other creditors 140,739 17,344
187,737 36,984

FSE HEALTHCARE LIMITED (REGISTERED NUMBER: 12781731)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2023


6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Philip Jones (Senior Statutory Auditor)
for and on behalf of Orcom Civvals Audit Limited

7. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

8. ULTIMATE CONTROLLING PARTY

The controlling party is FSE International S. A., a company registered in Belgium.